Endocrinology
Latest News
Dapagliflozin approved for reducing HF hospitalization in diabetes
It is the first SGLT2 inhibitor approved in the United States for this indication in adults with type 2 disease.
News
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
Conference Coverage
Machine learning–derived risk score predicts heart failure risk in diabetes patients
Highest WATCH-DM scores linked to 5-year heart failure risk approaching 20%.
Conference Coverage
Ticagrelor: Modest benefit, bigger bleed risk in diabetes plus stable CAD
Patients with prior PCI fared a bit better and may be a target population for long-term DAPT therapy.
News
FDA approves Baqsimi nasal powder for emergency hypoglycemia treatment
It is the first glucagon therapy approved for this indication that is administrable without an injection.
From the Journals
Fournier gangrene cases surge in patients using SGLT2 inhibitors
Serious complications and death are likely if Fournier gangrene is not recognized.
Conference Coverage
Restrictions on EMT glucagon administration should be lifted
“Increasing the availability of glucagon in the prehospital setting will likely result in reduced cost burden and adverse consequences of severe...
Clinical Review
Medical Mimics of Psychiatric Conditions, Part 2
News
Flamin’ hots
Dr. Francine Pearce discusses the correlation between a spicy snack teens love and visits to the ED.
Medicolegal Issues
Malpractice Counsel: Constipation, missing diabetes
Commentaries on cases involving a 26-year-old woman with a history of chronic constipation and a 27-year-old man with a 3-day history of severe...
Conference Coverage
WDC: Hemoglobin A1c screening catches diabetes in the hospital
In newly admitted patients with plasma glucose levels at or above 140 mg/dL, check hemoglobin A1c level to screen for diabetes.